These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26712376)

  • 1. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
    Mori T; Shibasaki Y; Matsumoto K; Shibasaki M; Hasegawa M; Wang E; Masukawa D; Yoshizawa K; Horie S; Suzuki T
    J Pharmacol Exp Ther; 2013 Oct; 347(1):91-9. PubMed ID: 23902939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Profile of Naldemedine, a Peripherally Acting
    Kanemasa T; Koike K; Takase K; Arai T; Nakamura A; Morioka Y; Hasegawa M
    J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice.
    Valle L; Pol O; Puig MM
    J Pharmacol Exp Ther; 2001 Feb; 296(2):378-87. PubMed ID: 11160621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of intracerebroventricularly-administered [D-Arg(2), beta-Ala(4)]-dermorphin (1-4) on gastrointestinal transit.
    Niijima F; Tan-No K; Esashi A; Nakagawasai O; Tadano T; Takahashi N; Yonezawa A; Sakurada S; Kisara K
    Peptides; 2000 Feb; 21(2):295-9. PubMed ID: 10764959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
    Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
    Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist.
    Xu B; Guo Y; Zhang M; Zhang R; Chen D; Zhang Q; Xiao J; Xu K; Li N; Qiu Y; Zhu H; Niu J; Zhang X; Fang Q
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13848. PubMed ID: 32281198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
    Reche I; Fuentes JA; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
    Shannon HE; Lutz EA
    Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
    Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
    Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies and antisense oligodeoxynucleotides to mu-opioid receptors, selectively block the effects of mu-opioid agonists on intestinal transit and permeability in mice.
    Pol O; Valle L; Sánchez-Blázquez P; Garzón J; Puig MM
    Br J Pharmacol; 1999 May; 127(2):397-404. PubMed ID: 10385239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit.
    Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):165-9. PubMed ID: 7796321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
    Zhang T; Han Z; Shi X; Zhao W; Wang Z; Zhang R; Xu B; Zhang M; Zhang Q; Xiao J; Zhu H; Zheng T; Fang Q
    Bioorg Med Chem; 2019 Feb; 27(4):630-643. PubMed ID: 30626554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.